Search This Blog

Monday, June 16, 2025

'Bill Ackman urges US to help Israel destroy Iran’s nuclear program, cites ‘low risk, high reward''

 Bill Ackman is calling on the US to militarily support Israel in a campaign to “destroy Iran’s nuclear capability,” arguing that such a move would be in America’s own national interest and could be carried out at low cost and minimal risk.

In a series of posts on X over the weekend, the hedge-fund billionaire laid out a detailed case for why the US should join Israel’s ongoing operations against Iran, suggesting that the moment presents “the lowest-risk, highest-probability” opportunity to eliminate a threat that some claim has endangered global security.

“The parade was great. Our military is incredible. And now @Israel needs our help to destroy Iran’s nuclear threat to the world,” Ackman wrote on Saturday, referencing the weekend’s military parade in Washington, DC.

Billionaire hedge fund manager Bill Ackman (seen right with Steve Forbes in New York on June 5) is calling for the US to join Israel in its bid to destroy Iran’s nuclear facilities.Getty Images

President Donald Trump told ABC News over the weekend that the US is “not involved” in the ongoing conflict, though he added: “It’s possible we could get involved. But we are not at this moment involved.”

Israel has urged the Trump administration to join its war against Iran to destroy the Fordow nuclear facility, but while Israeli officials claim Trump expressed willingness to assist if necessary, US officials denied to Axios that they made any commitment.

They told the online news outlet that the administration is currently not considering involvement.

Ackman, whose wife, the former MIT academic Neri Oxman, is Israeli, argued that Israel’s initial blows against the Iranian military infrastructure and its top leadership late last week gave the US a chance to intervene at relatively low cost.

“Israel’s military and air force have sufficiently degraded Iran’s defenses such that this is now the lowest-risk, highest-probability moment to take out Iran’s nuclear capability, a grave threat to us all,” the Pershing Square Capital Management CEO added.

Ackman, who has been a vocal supporter of Israel and a fierce critic of colleges and universities over their attitudes toward perceived antisemitism on campus, stressed that the intervention he’s advocating would not require “boots on the ground,” but rather US bombers and bunker-busting bombs that Israel lacks.

Fire and smoke rise into the sky after an Israeli attack on the Shahran oil depot in Tehran on Sunday.Getty Images

“Israel does not have the equipment and armaments to complete the job. We do, and it does not require boots on the ground,” he said.

“The war Israel has been fighting has been on behalf of all of us. Let’s help them finish the job.”

The financier followed up with a lengthier post on Sunday in which he addressed critics and framed his argument in explicitly “America First” terms, contending that a nuclear-armed Iran would pose a direct and escalating threat to the US.

“Iran has made it entirely clear that Israel is not their only target,” Ackman wrote.

“It’s possible we could get involved. But we are not at this moment involved,” President Trump said over the weekend.REUTERS

“The Iranian leadership has for decades continually called not only for ‘Death to Israel,’ but also for ‘Death to America’ as the ‘Great Satan.’”

He warned that a nuclear-capable Iran would upend global oil markets and drive up domestic energy prices by threatening Saudi Arabia, Qatar and Gulf shipping routes.

“Even if you don’t care about Israel and you only care about the price of gas at the pump, you don’t want Iran to have the nuke,” Ackman said.

Ackman argued that the destruction of Iran’s nuclear infrastructure and the weakening of the Islamic Revolutionary Guard Corps (IRGC) would reduce terrorism, lower global shipping costs and open the door to greater peace and economic development in the region — what he called a “massive peace dividend” for the US.

“The Houthis have attacked more than 100 ships… massively disrupting trade,” he noted.

“Eliminating Iran’s nuclear threat and the IRGC’s funding of the Houthis will dramatically reduce these costs and risks.”

Ackman’s wife, the former MIT academic Neri Oxman, is Israeli. The couple is seen above in New York City in November 2024.Patrick McMullan

He added that recent Israeli strikes had already “made remarkable progress” in degrading Iran’s defenses and that American assistance would serve as the final blow.

“Unfortunately, however, Israel will only be able to delay Iran’s nuclear capability and not destroy it without our assistance, in particular, without our bombers and massive ordinance penetration bombs.”

Ackman cited Trump to bolster his case, quoting him as saying: “You can’t have peace if Iran has a nuclear weapon.”

He concluded his thoughts on social media by dismissing concerns that US involvement could spark a wider war.

“There is no real risk of ‘being dragged into a long war,” Ackman insisted.

He described the intervention as “a short-term tactical participation” and suggested the IRGC’s grip on power was already slipping.

An Ultra-Orthodox Jewish man inspects the damage at a Jewish orthodox girls’ school after Iranian ballistic missiles hit Bnei Brak, Israel on Sunday.ABIR SULTAN/EPA-EFE/Shutterstock

“A denuclearized Iran with new leadership is much lower risk to the United States than the current regime,” he said.

“You don’t need to care about Israel to conclude that using a limited amount of US military assets for a few days to eliminate Iran’s ability to become a nuclear power makes sense.”

Meanwhile, lawmakers on both sides of the aisle have urged Trump not to enter the fray.

“Israel doesn’t need US taxpayers’ money for defense if it already has enough to start offensive wars,” Rep. Thomas Massie (R-Ky.) wrote on X. “I vote not to fund this war of aggression.”

“Netanyahu’s reckless strike risks provoking a wider war and pulling in the United States.”

Rep. Greg Casar (D-Texas) wrote on X: “Trump must oppose Netanyahu’s escalation and pursue a diplomatic path to deal with Iran’s nuclear program.”

The Post has sought comment from Ackman.

https://nypost.com/2025/06/16/business/bill-ackman-urges-us-to-help-israel-destroy-irans-nuclear-program/

Iran’s intelligence chief among latest key senior officials killed in Israeli airstrikes

 Iran’s intelligence chief and other key senior officials have been killed in an Israeli airstrike — further decimating Tehran’s military leadership, according to the Israel Defense Forces.

Mohammed Kazemi, the elite Islamic Revolutionary Guard Corps’ head of intelligence, was killed Sunday alongside his deputy, Hassan Mohaqiq, and others during an attack on Tehran, the IDF said.

Israeli forces were able to take out the three at once while they were attending a meeting, the IDF said.

Mohammed Kazemi, the head of intelligence for the Islamic Revolutionary Guard Corps.Tasnim News Agency
Footage from the strike on surface-to-surface missile launchers in Iran.IDF

“[Israeli] fighter jets, following precise IDF intelligence, struck a structure in Tehran where several senior officials from Iranian intelligence organizations were located,” the IDF said.

“These officials played a central role in shaping Iran’s strategic assessments and planning terrorist attacks against Israel, the West, and countries in the Middle East.”

Kazemi had been the Revolutionary Guard’s chief of intelligence since 2022 and was responsible for leading counterintelligence and espionage operations — including weeding out Iranian citizens who opposed the regime.

Footage of the airstrikes that killed key Iranian officials.IDF

Mohaqiq previously served as chair of the Guard’s Strategic Intelligence Division, the IDF said.

Kazemi’s death was first revealed by Israeli Prime Minister Benjamin Netanyahu.

Mohammad Kazemi, head of IRGC intelligence, was reportedly killed.IDF

“Moments ago, we also got the chief intelligence officer and his deputy in Tehran,” Netanyahu told Fox News in an interview on Sunday afternoon from an undisclosed location in Israel.

“Our brave pilots are over the skies of Tehran, and we’re targeting military sites, nuclear sites,” he added.

His death was later confirmed by Iran’s Revolutionary Guard.

Mohammad Hassan Mohaqiq, his deputy, was also reportedly killed.IDF

Quds Force Intelligence Department head Mohsen Bakri and his deputy, Abu al-Fadl Nikouei, were also killed in the strike.

The Quds Force is a powerful branch within the Revolutionary Guards Corps that supports non-state organizations in several countries.

The pair played a significant role in Iran’s efforts to maintain its presence in Syria and support Hezbollah in Lebanon, according to the IDF.

The strike follows an Israeli strike last week that killed Mohammad Bagheri, head of the Intelligence Directorate in the Iranian armed forces general staff and the country’s top-ranking military official.

Footage of the strike on surface-to-surface missile launches in Iran.IDF
“This marks a significant blow to the Iranian regime’s intelligence apparatus and its ability to carry out terrorist attacks against the State of Israel,” the IDF said.

Israel has taken out dozens of Iran’s top military leaders and scientists since it began its bombing campaign on Thursday, targeting nuclear and military sites after talks to reach a deal on Iran’s rapidly advancing nuclear program failed.

https://nypost.com/2025/06/16/world-news/irans-intelligence-chief-among-latest-key-senior-officials-killed-in-israeli-airstrikes/

Kulldorff, Fired From Harvard After Refusing COVID Shot, Named To CDC Vaccine Panel

 by Jennifer Kabbany via The College Fix,

World-renowned infectious-disease epidemiologist Martin Kulldorff — who was fired from Harvard Medical School last year after refusing the COVID vaccine — just got a new gig.

Kulldorff has been named a member of the Centers for Disease Control and Prevention’s Advisory Committee for Immunization Practices.

Kulldorff, who had refused the COVID vaccine because of his infection-acquired immunity, lost his appointment at a Harvard-affiliated hospital in the early days of the COVID era, and in March of 2024 was officially terminated as a med school faculty member.

Since the COVID lockdowns began five years ago this month, Kulldorff argued that tactics such as social distancing, masking children, vaccines after infections, and other extreme measures were not the best course of action to fight the virus.

He co-authored the Great Barrington Declaration, which called for sensible tactics that would allow the globe to reach “herd immunity” and has been signed by nearly 1 million scientists worldwide.

Health Secretary Robert F. Kennedy Jr., in announcing the new members of the panel last week on X, wrote that his selections signify a “major step towards restoring public trust in vaccines.”

Kennedy wrote he retired the 17 current members of the committee and is repopulating ACIP with eight new members “committed to evidence-based medicine, gold-standard science, and common sense.”

“They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations. The committee will review safety and efficacy data for the current schedule as well,” Kennedy stated.

MassLive reported that in 2021, “Kulldorff posted on X that ‘thinking that everyone must be vaccinated is as scientifically flawed as thinking that nobody should.'”

“COVID vaccines are important for older high-risk people and their care-takers,” he wrote. “Those with prior natural infection do not need it. Nor children.”

According to the New York Times, after Kennedy’s announcement, some infectious disease and vaccine experts accused the health secretary of going back on his pledge not to pick so-called anti-vaxxers.

“When Mr. Kennedy fired the entire committee, known as the A.C.I.P., he cited financial conflicts of interest and said a clean sweep was necessary to restore public trust in vaccination,” the Times reported.

As for Harvard’s role in the controversy, writing in City Journal last year, Kulldorff argued that Harvard turned its back on him, open debate, and medical freedom.

“The beauty of our immune system is that those who recover from an infection are protected if and when they are re-exposed. This has been known since the Athenian Plague of 430 BC—but it is no longer known at Harvard,” he wrote.

“Three prominent Harvard faculty coauthored the now infamous ‘consensus’ memorandum in The Lancet, questioning the existence of Covid-acquired immunity. By continuing to mandate the vaccine for students with a prior Covid infection, Harvard is de facto denying 2,500 years of science.”

Kennedy, in announcing Kulldorff, noted he is a biostatistician and “a leading expert in vaccine safety and infectious disease surveillance.”

“… Dr. Kulldorff developed widely used tools such as SaTScan and TreeScan for detecting disease outbreaks and vaccine adverse events. His expertise includes statistical methods for public health surveillance, immunization safety, and infectious disease epidemiology. He has also been an influential voice in public health policy, advocating for evidence-based approaches to pandemic response.”

https://www.zerohedge.com/medical/epidemiologist-who-was-fired-harvard-after-refusing-covid-shot-named-cdc-vaccine-panel

'NextCure Joins China-ADC Gold Rush with $745M Simcere Deal''

 

The deal gets NextCure the rights to Simcere’s novel ADC for solid tumors outside of China.

NextCure is joining the China biopharma gold rush, partnering with Simcere Pharmaceutical Group on development of a novel antibody-drug conjugate for treating solid tumors.

Through the deal announced Monday, the Maryland-based company gets ex-China rights to SIM0505, an ADC developed by Simcere that targets CDH6 combined with a topoisomerase 1 inhibitor. NextCure will pay Simcere an undisclosed upfront fee, plus development, regulatory and sales milestones for sales outside of China, adding up to as much as $745 million.

“[Simcere’s] proprietary payload is a potent cytotoxin with a potentially improved safety and efficacy profile compared to other topoisomerase inhibitors,” Michael Richman, NextCure’s president and CEO, said in the statement announcing the deal.

NextCure’s stock was worth about 70 cents apiece before trading began Monday and fell to 50 cents by Monday afternoon, a 26% drop.

The deal also gives NextCure the rights to linker and topoisomerase payload technology developed by Simcere. NextCure will use that tech to develop another ADC on an unannounced preclinical target.

Simcere already has SIM0505 in Phase I dose escalation trials in China. NextCure will take the developmental reins in the U.S. and begin its own Phase I trial in the third quarter of 2025.

Adding SIM0505 to its pipeline brings NextCure’s total offerings to two, the other molecule being LNCB74, another ADC for solid tumors. That therapy is being developed together with LigaChem. The antibody in that ADC had at one time been in development on its own, but NextCure shifted its work to an ADC formulation in late 2023. LNCB74 is currently in a Phase I dose escalation trial.

The SIM0505 deal is part of a massive recent trend in biopharma of grabbing assets from Chinese biotechs. Obesity drugs have gotten the lion’s share of attention recently, but ADCs have had just as much activity. GSK alone in the last two years has gotten two separate ADCs from DualityBio and Hansoh Pharma for gastrointestinal and lung cancers as well as sarcomas, spending close to $3 billion for the two molecules. Gilead spent $415 million in biobucks to shore up its ADC pipeline in December 2024 with a deal to use Tubulis’ conjugation technology on “ultra-stable ADCs.” Roche dropped $1 billion in January on a Phase I ADC from Innovent in small cell lung cancers.

https://www.biospace.com/business/nextcure-joins-china-adc-gold-rush-with-745m-simcere-deal

Starmer says US-UK trade deal to be completed 'very soon,' Trump proclamation expected

 Britain and the United States should finalize "very soon" the implementation of a trade deal agreed last month, Prime Minister Keir Starmer said on Monday ahead of a meeting with U.S. President Donald Trump in Canada.

Trump is expected to sign a proclamation on the terms of the deal covering steel, ethanol, autos and beef, three sources familiar with the matter said on Monday.

Work on the proclamation had been completed, but it was not immediately clear if Trump would sign it when he meets Starmer later on Monday, the sources said.

"I'm certainly seeing President Trump today, and I'm going to discuss with him our trade deal," Starmer told reporters on the sidelines of a Group of Seven (G7) meeting.

"I'm very pleased that we made that trade deal, and we're in the final stages now of implementation, and I expect that to be completed very soon."

Britain was the first country to agree a deal for lower tariffs from Trump, with the U.S. reducing tariffs on imports of UK cars, aluminium and steel, and Britain agreeing to lower tariffs on U.S. beef and ethanol.

But implementation of the deal has been delayed while details were being hammered out. The proclamation readied by the White House will set an effective date in coming weeks, one of the sources said.

On steel and aluminium, the U.S. agreed to lower the 25% tariffs on imports from Britain to zero, subject to setting a quota for British steel imports that must meet supply chain requirements.

Britain had avoided tariffs of up to 50% on steel and aluminium that the U.S. imposed on other countries earlier this month, but could face elevated tariffs from July 9 unless a deal to implement the tariff reduction is reached.

https://www.yahoo.com/news/us-uk-trade-deal-completed-145553431.html